Christ, Arlesheim

Andreas Christ, Arlesheim CH

Patent application number	Description	Published
20090163517	BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES - This invention is concerned with compounds of the formula	06-25-2009
20090208971	Insulin promoter factor 1 as target/marker of beta cell failure - The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of IPF-1 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.	08-20-2009
20090215069	Pancreatic polypeptide as target/marker of beta cell failure - The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of pancreatic hormone in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.	08-27-2009
20100009462	Timp-2 as target/marker of beta cell failure - The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of TIMP-2 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.	01-14-2010

Patent applications by Andreas Christ, Arlesheim CH

Patent application number	Description	Published
20080293756	4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES - This invention relates to 4,4-disubstituted piperidine derivatives of the formula	11-27-2008
20080306116	ARYLOXAZOLE, ARYLOXADIAZOLE AND BENZIMIDAZOLE DERIVATIVES - This invention relates to compounds of the formula	12-11-2008
20100069413	Pyrimidine and Quinazoline Derivatives - This invention is concerned with compounds of the formula	03-18-2010
20100222350	PHENYL, PYRIDINE, QUINOLINE, ISOQUINOLINE, NAPHTHYRIDINE AND PYRAZINE DERIVATIVES - This invention is concerned with compounds of the formula	09-02-2010